Literature DB >> 16580675

Genetic variability at the leptin receptor (LEPR) locus is a determinant of plasma fibrinogen and C-reactive protein levels.

Yuan-Yuan Zhang1, Lucia Gottardo, Wojciech Mlynarski, Winfred Frazier, David Nolan, Jill Duffy, Maria Cristina Marescotti, Ernest V Gervino, Michael T Johnstone, Christos S Mantzoros, Angelo Avogaro, Alessandro Doria.   

Abstract

OBJECTIVE: Cellular and animal studies suggest that leptin has proinflammatory and prothrombotic effects that could link increased adipose mass directly to atherogenesis. To investigate this hypothesis, we examined the effect of genetic variability at the leptin receptor (LEPR) locus on the plasma levels of fibrinogen and CRP--two markers of inflammation and susceptibility to atherosclerosis. METHODS AND
RESULTS: Linkage disequilibrium analysis of 71 single-nucleotide polymorphisms (SNPs) spanning the LEPR locus revealed four haplotype blocks that could be tagged by 11 SNPs. In 630 healthy Caucasian individuals, variability in block #4 was significantly associated with plasma fibrinogen (p=0.005), accounting for 3% of its variance (r2=0.030). The same block was also associated with CRP levels (p=0.049, r2=0.022). The effect was strongest for two of the SNPs in this block. At rs3790432, fibrinogen was 10% higher in minor allele homozygotes than in major allele homozygotes and intermediate in heterozygotes (p=0.015). At rs1805096, it was 5% higher (p=0.007) and CRP 32% higher (p=0.011) in major allele homozygotes than in minor allele carriers. This pattern of association was also evident in the haplotype analysis.
CONCLUSIONS: Association of leptin receptor variability with inflammatory traits supports the hypothesis that leptin may play a role in atherogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16580675     DOI: 10.1016/j.atherosclerosis.2006.02.043

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  19 in total

1.  Single-nucleotide polymorphisms at five loci are associated with C-reactive protein levels in a cohort of Filipino young adults.

Authors:  Ghenadie Curocichin; Ying Wu; Thomas W McDade; Christopher W Kuzawa; Judith B Borja; Li Qin; Ethan M Lange; Linda S Adair; Leslie A Lange; Karen L Mohlke
Journal:  J Hum Genet       Date:  2011-09-22       Impact factor: 3.172

2.  C-reactive protein modifies the association of plasma leptin with coronary calcium in asymptomatic overweight individuals.

Authors:  Seth S Martin; Atif N Qasim; Dan J Rader; Muredach P Reilly
Journal:  Obesity (Silver Spring)       Date:  2011-07-07       Impact factor: 5.002

3.  Sex difference and the role of leptin in the association between high-sensitivity C-reactive protein and adiposity in two different populations.

Authors:  Isabelle Anne Rossi; Murielle Bochud; Pascal Bovet; Fred Paccaud; Gérard Waeber; Peter Vollenweider; Patrick Taffé
Journal:  Eur J Epidemiol       Date:  2012-03-06       Impact factor: 8.082

4.  Novel locus for fibrinogen in 3' region of LEPR gene in island population of Vis (Croatia).

Authors:  Željka Tomas; Matea Zajc Petranović; Tatjana Škarić-Jurić; Ana Barešić; Marijana Peričić Salihović; Nina Smolej Narančić
Journal:  J Hum Genet       Date:  2014-10-09       Impact factor: 3.172

5.  Gene-Environment Interactions and the Risk of Barrett's Esophagus in Three US Cohorts.

Authors:  Marta Crous-Bou; Manol Jovani; Immaculata De Vivo; Brian C Jacobson
Journal:  Am J Gastroenterol       Date:  2019-06       Impact factor: 10.864

6.  Targeting 160 candidate genes for blood pressure regulation with a genome-wide genotyping array.

Authors:  Siim Sõber; Elin Org; Katrin Kepp; Peeter Juhanson; Susana Eyheramendy; Christian Gieger; Peter Lichtner; Norman Klopp; Gudrun Veldre; Margus Viigimaa; Angela Döring; Margus Putku; Piret Kelgo; Sue Shaw-Hawkins; Philip Howard; Abiodun Onipinla; Richard J Dobson; Stephen J Newhouse; Morris Brown; Anna Dominiczak; John Connell; Nilesh Samani; Martin Farrall; Mark J Caulfield; Patricia B Munroe; Thomas Illig; H-Erich Wichmann; Thomas Meitinger; Maris Laan
Journal:  PLoS One       Date:  2009-06-29       Impact factor: 3.240

7.  Leptin receptor (LEPR) SNP polymorphisms in HELLP syndrome patients determined by quantitative real-time PCR and melting curve analysis.

Authors:  Tibor Várkonyi; Levente Lázár; Attila Molvarec; Nándor Gábor Than; János Rigó; Bálint Nagy
Journal:  BMC Med Genet       Date:  2010-02-11       Impact factor: 2.103

8.  Genome-wide association study identifies two novel regions at 11p15.5-p13 and 1p31 with major impact on acute-phase serum amyloid A.

Authors:  Carola Marzi; Eva Albrecht; Pirro G Hysi; Vasiliki Lagou; Melanie Waldenberger; Anke Tönjes; Inga Prokopenko; Katharina Heim; Hannah Blackburn; Janina S Ried; Marcus E Kleber; Massimo Mangino; Barbara Thorand; Annette Peters; Christopher J Hammond; Harald Grallert; Bernhard O Boehm; Peter Kovacs; Ludwig Geistlinger; Holger Prokisch; Bernhard R Winkelmann; Tim D Spector; H-Erich Wichmann; Michael Stumvoll; Nicole Soranzo; Winfried März; Wolfgang Koenig; Thomas Illig; Christian Gieger
Journal:  PLoS Genet       Date:  2010-11-18       Impact factor: 5.917

9.  Polymorphisms of the HNF1A gene encoding hepatocyte nuclear factor-1 alpha are associated with C-reactive protein.

Authors:  Alexander P Reiner; Mathew J Barber; Yongtao Guan; Paul M Ridker; Leslie A Lange; Daniel I Chasman; Jeremy D Walston; Gregory M Cooper; Nancy S Jenny; Mark J Rieder; J Peter Durda; Joshua D Smith; John Novembre; Russell P Tracy; Jerome I Rotter; Matthew Stephens; Deborah A Nickerson; Ronald M Krauss
Journal:  Am J Hum Genet       Date:  2008-04-24       Impact factor: 11.025

10.  Loci related to metabolic-syndrome pathways including LEPR,HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women's Genome Health Study.

Authors:  Paul M Ridker; Guillaume Pare; Alex Parker; Robert Y L Zee; Jacqueline S Danik; Julie E Buring; David Kwiatkowski; Nancy R Cook; Joseph P Miletich; Daniel I Chasman
Journal:  Am J Hum Genet       Date:  2008-04-24       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.